REFERENCES
- Alberti I., Kalia Y. N., Naik A., Bonny J., Guy R. H. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int. J. Pharm. 2001; 219: 11–19
- Brenman B., Leyden J. J. Overview of topical therapy for common superficial fungal infections and the role of new topical agents. J. Am. Acad. Dermatol. 1997; 36: 53–58
- Bronaugh R. L., Stewart R. F. Methods for in vitro percutaneous absorption studies III: hydrophobic compounds. J. Pharm. Sci. 1984; 73: 1255–1258
- Degreef H. J., De-Doncker P. R. G. Current therapy of dermatophytosis. J. Am. Acad. Dermatol. 1994; 31: S25–S30
- Dick I. P., Scott R. C. Pig ear skin as an in vitro model for human skin permeability. J. Pharm. Pharmacol. 1992; 44: 640–645
- Diembeck W., Beck H., Benech-Kieffer F., Courtellemont P., Dupuis J., Lovell W., Paye M., Spengler J., Steiling W. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem. Toxicol. 1999; 37: 191–205
- Drake L. A., Dinehart S. M., Farmer E. R., Goltz R. W., et al. Guidelines of care for superficial mycotic infections of the skin: tinea corporis, tinea curis, tinea faciei, tinea manuum and tinea pedis. J. Am. Acad. Dermatol. 1996; 34: 282–286
- Faergemann J. Pharmacokinetics of fluconozole in skin and nails. J. Am. Acad. Dermatol. 1999; 40: S14–S20
- Faergemann J., Laufen H. Levels of fluconazole in serum, stratum correum, epidemis-dermis (without stratum correum) and ecrine sweet. Clin. Exp. Dermatol. 1993; 18: 102–106
- Ferreira L. A. M., Doucet J., Seiller M., Grossiord J. L., Marty J. P., Wepierre J. In vitro percutaneous absorption of metronidazole and glucose: comparison of w/o, w/o/w and w/o systems. Int. J. Pharm. 1995; 112: 169–179
- Klimke K., Schäfer-Korting M. Effect of keratin on the efficacy of fluconozole. Mycoses 1997; 40: 43–46
- Lesher J. L. Oral therapy of common superficial fungal infections of the skin. J. Am. Acad. Dermatol. 1999; 40: S31–S34
- Mathy F. X., Ntivunwa D., Verbeeck R. K., Préat V. Fluconazole distribution in rat dermis following intravenous and topical application: a microdialysis study. J. Pharm. Sci. 2005; 94: 770–780
- Moser K., Kriwet K., Naik A., Kalia Y. N., Guy R. H. Passive skin penetration enhancement and its quantification in vitro. Eur. J. Pharm. Biopharm. 2001a; 52: 103–112
- Moser K., Kriwet K., Kalia Y. N., Guy R. H. Enhanced skin permeation of a lipophilic drug using supersaturated formulations. J. Contr. Release 2001b; 73: 245–253
- Odom R. B. Common superficial fungal infections in immunosupressed patients. J. Am. Acad. Dermatol. 1994; 31: S56–S59
- Odom R. B. Update on topical therapy for superficial fungal infections: focus on butenafine. J. Am. Acad. Dermatol. 1997; 36: S1–S2
- Piérard G. E., Arrese J. E., Piérard-Franchimont C. Treatment and prophylaxis of tinea infections. Drugs 1996; 52: 209–224
- Roy S. D., Hou S. -Y., Witham S. L., Glynn G. L. Transdermal delivery of narcotic analgesics: comparative metabolism and permeability of human cadaver and hairless mouse skin. J. Pharm. Sci. 1994; 83: 1723–1728
- Simon G. A., Maibach H. I. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol. Appl. Skin Physiol. 2000; 13: 229–234
- Surber C., Wilhelm K. P., Maibach H. I. In-vitro skin pharmacokinetics of acitretin: percutaneous absorption studies in intact and modified skin from three different species using different receptor solutions. J. Pharm. Pharmacol. 1991; 43: 836–840
- Touitou E., Meidan V. M., Horwitz E. Methods for quantitative determination of drug localized in the skin. J. Contr. Release 1998; 56: 7–21
- Trottet L., Merly C., Mirza M., Hadgraft J., Davis A. F. Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride. Int. J. Pharm. 2004; 274: 213–219
- Virgili A., Zampino M. R., Mantovani L. Fungal skin infections in organ transplant recipients. Am. J. Clin. Dermatol. 2002; 3: 19–35
- Wildfeuer A., Faergemann J., Laufen H., Pfaff G., Zimmermann T., Seidl H. P., Lach P. Bioavailability of fluconazole in the skin after oral medication. Mycoses 1994; 37: 127–130
- William A. C., Barry B. W. Chemical penetration enhancement: Possibilities and problems. Dermal Absorption and Toxicity Assessment, M. S. Roberts, K. A. Walters. Marcel Dekker, Inc, New York 1998; 297–312